CD8A and ovarian cancer: Adair et al.113demonstrated that the treatment of ovarian cancer cells with DAC can lead to a large increase in the expression of multiple CTA genes, a modest increase in the expression of class I MHC proteins, and enhance the recognition of the treated cells by antigen‐specific CD8+ T cells.